SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Advent Convertible and Income Fund (AVK) trades at a trailing P/E of 4.6. Trailing earnings yield is 21.65%. PEG 0.40 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (4.6); PEG ≤ 1.0 — Peter Lynch undervalued (0.40); earnings yield beats bond yields (21.65%).
- PEG Ratio 0.40 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 21.65% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 65/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AVK
Valuation Multiples
P/E (TTM)4.6
Forward P/EN/A
PEG Ratio0.40
Forward PEGN/A
P/B Ratio0.00
P/S Ratio5.37
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.69
Book Value / Share$0.00
Revenue / Share$2.31
FCF / Share$0.00
Yields & Fair Value
Earnings Yield21.65%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$39,283.00 |
$4.51M |
$10.88M |
241.4% |
| 2017 |
$2.55 |
$60.76M |
$58.35M |
96% |
| 2018 |
$-0.47 |
$-13.35M |
$-16.21M |
- |
| 2019 |
$1.54 |
$56.95M |
$53.26M |
93.5% |
| 2020 |
$1.12 |
$43.13M |
$38.73M |
89.8% |
| 2021 |
$5.49 |
$193.7M |
$189.56M |
97.9% |
| 2022 |
$-4.94 |
$-167.33M |
$-170.86M |
- |
| 2023 |
$-0.19 |
$-3.53M |
$-7.02M |
- |
| 2024 |
$2.41 |
$110.08M |
$106.5M |
96.7% |
| 2025 |
$2.69 |
$102.06M |
$118.64M |
116.2% |
